IRIS
DEL POETA, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 71.981
AS - Asia 6.639
EU - Europa 6.612
SA - Sud America 993
Continente sconosciuto - Info sul continente non disponibili 435
AF - Africa 95
OC - Oceania 19
Totale 86.774
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 71.747
SG - Singapore 2.929
DE - Germania 1.803
CN - Cina 1.510
UA - Ucraina 1.018
RU - Federazione Russa 935
BR - Brasile 802
IT - Italia 688
IE - Irlanda 636
HK - Hong Kong 620
VN - Vietnam 536
GB - Regno Unito 417
FR - Francia 303
BD - Bangladesh 264
SE - Svezia 261
FI - Finlandia 250
KR - Corea 219
JP - Giappone 183
CA - Canada 123
IN - India 87
NL - Olanda 72
AR - Argentina 53
PL - Polonia 52
MX - Messico 47
ZA - Sudafrica 43
TR - Turchia 36
AT - Austria 35
UZ - Uzbekistan 32
ES - Italia 30
BE - Belgio 27
EC - Ecuador 27
PH - Filippine 27
ID - Indonesia 24
IQ - Iraq 24
CL - Cile 20
SA - Arabia Saudita 20
CO - Colombia 19
VE - Venezuela 19
UY - Uruguay 17
PE - Perù 16
PY - Paraguay 16
TH - Thailandia 16
AU - Australia 15
CZ - Repubblica Ceca 14
JM - Giamaica 14
PK - Pakistan 13
CH - Svizzera 9
EU - Europa 9
IL - Israele 9
KE - Kenya 9
LT - Lituania 9
MY - Malesia 9
EG - Egitto 8
MA - Marocco 8
NP - Nepal 8
A2 - ???statistics.table.value.countryCode.A2??? 7
AE - Emirati Arabi Uniti 7
JO - Giordania 7
KZ - Kazakistan 7
RO - Romania 7
SN - Senegal 7
AL - Albania 6
DK - Danimarca 6
DM - Dominica 6
DO - Repubblica Dominicana 6
DZ - Algeria 6
GR - Grecia 6
HN - Honduras 6
LB - Libano 6
TN - Tunisia 6
AZ - Azerbaigian 5
CR - Costa Rica 5
GT - Guatemala 5
IR - Iran 5
KG - Kirghizistan 5
BB - Barbados 4
BY - Bielorussia 4
HR - Croazia 4
NO - Norvegia 4
OM - Oman 4
PR - Porto Rico 4
PT - Portogallo 4
AO - Angola 3
BH - Bahrain 3
BO - Bolivia 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
NZ - Nuova Zelanda 3
QA - Qatar 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BW - Botswana 2
CY - Cipro 2
GD - Grenada 2
GE - Georgia 2
KW - Kuwait 2
MD - Moldavia 2
MN - Mongolia 2
Totale 86.331
Salva come PNG Salva come JPEG
Città #
Woodbridge 22.017
Wilmington 17.838
Houston 15.527
Fairfield 2.049
Ann Arbor 1.727
Singapore 1.662
Ashburn 1.373
Chandler 1.132
Jacksonville 920
Seattle 850
San Jose 796
Cambridge 712
Dublin 625
Hong Kong 604
Beijing 573
Dearborn 519
Medford 466
New York 325
Santa Clara 321
The Dalles 280
Dallas 249
Council Bluffs 232
Lawrence 219
Los Angeles 197
Ho Chi Minh City 182
Zhengzhou 173
Buffalo 145
Tokyo 143
Moscow 140
Rome 136
Lauterbourg 133
Hanoi 128
Mülheim 106
San Diego 105
São Paulo 78
Munich 76
Milan 75
Chicago 65
Menlo Park 62
University Park 49
London 48
Hefei 46
Boardman 43
Phoenix 43
Mountain View 42
Nanjing 42
Brooklyn 41
Norwalk 41
Montreal 40
Orem 39
Redondo Beach 39
Shanghai 38
Warsaw 38
Nuremberg 36
Helsinki 34
Creede 32
Frankfurt am Main 32
Toronto 31
Falls Church 29
Johannesburg 28
Palo Alto 28
Verona 27
Denver 26
Kunming 26
Redwood City 26
Guangzhou 25
Brussels 23
San Francisco 23
Chennai 22
Columbus 22
Haiphong 21
Rio de Janeiro 21
Atlanta 20
Da Nang 19
Detroit 19
Belo Horizonte 18
Boston 18
Naples 18
Manchester 17
Mexico City 17
Poplar 17
Saint Petersburg 17
Wuhan 17
Amsterdam 16
Montevideo 15
Nürnberg 15
Brasília 14
Lima 14
North Bergen 14
Stockholm 14
Ankara 13
Bologna 13
Chengdu 13
Louisville 13
Seoul 13
Turku 13
Brno 12
Florence 12
Hangzhou 12
Biên Hòa 11
Totale 74.485
Salva come PNG Salva come JPEG
Nome #
Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia 641
Enumeration of CD34+ hematopoietic progenitor cells for clinical transplantation: comparison of three different methods 552
Femoral catheters: safety and efficacy in peripheral blood stem cell collection 543
A microgranular variant of acute promyelocytic leukemia with atypical morpho-cytochemical features and an early myeloid immunophenotype 537
CD7 expression in acute myeloid leukemia 530
Enumeration of CD34+ hematopoietic progenitor cells for clinical transplantation: comparison of three different methods 524
A case of SRSF2 mutation in chronic lymphocytic leukemia 519
AML-M0: A review of laboratory features and proposal of new diagnostic criteria 516
A novel t(11;12)(q23-24;q24) in a case of minimally-differentiated acute myeloid leukemia (AML-M0) 515
Collection of peripheral progenitor cells: a comparison between Amicus and Cobe-Spectra blood cell separators 513
Analysis of the expression of adhesion molecules on CD34+ progenitors from bone marrow, umbilical cord blood and G-CSF mobilized peripheral blood 504
Autologous peripheral blood stem cell transplantation as first line treatment of multiple myeloma: an Italian multicenter study 501
Minimally differentiated acute myeloid leukemia (AML-MO): a distinct clinico-biologic entity with poor prognosis 500
Graft failure due to hemolytic uremic syndrome recurrence 499
A phase-II trial of all trans retinoic acid and low-dose cytosine arabinoside for the treatment of high-risk myelodysplastic syndromes 498
All-trans-retinoic acid plus low-doses of cytarabine for the treatment of poor-risk acute myeloid leukemias 497
Positive selection of CD34+ cells by immunoadsorption: factors affecting the final yield and hematopoietic recovery in patients with hematological malignancies and solid tumors 495
Clinical significance of CD38 expression in chronic lymphocytic leukemia 494
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia 493
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments 490
High expression levels of vla-4 (CD49d) on mobilised peripheral blood stem cells are associated with rapid engraftment in multiple myeloma patients receiving autologous transplant 489
Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML) 485
P-glycoprotein and terminal transferase expression identify prognostic subsets within cytogenetic risk classes in acute myeloid leukemia 485
Leukocyte alkaline-phosphatase score in plasma-cell dyscrasias - correlation with disease severity and circulating levels of granulocyte-colony-stimulating factor 478
Acute lymphoblastic leukemia subsequent to autoimmune hemolytic anemia: a case report 477
Multiparametric analysis for the enumeration of CD34+ cells from bone marrow and stimulated peripheral blood 477
Comparison between conventional banding analysis and FISH screening with an AML specific set of probes in 260 patients 475
Biological profile of 23 cases of minimally differentiated acute myeloid leukemia (AML-MO) and its clinical implications 475
The kinetics of reduction of minimal residual disease impacts on duration of response and survival of patients with acute myeloid leukemia. 474
Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemia. 473
Intensive treatment of patients age 60 years and older with de novo acute myeloid leukemia - Analysis of prognostic factors 473
Surface-antigen expression profiling (SEP) in B-cell chronic lymphocytic leukemia (B-CLL): Identification of markers with prognostic relevance 472
Central Nervous System Involvement in Adult Acute Lymphoblastic Leukemia: Diagnostic Tools, Prophylaxis, and Therapy. 472
Diagnosis of acute myeloid leukemia and system Coulter VCS 471
Prognostic relevance of the expression of Tdt and CD7 in 335 cases of acute myeloid leukemia 468
Femoral catheters: safety and efficacy in peripheral blood stem cell collection 467
Efficacy and safety of human leucocyte interferon-alpha treatment in patients younger than 60 years of age with polycythaemia vera 466
All-trans retinoic acid (ATRA) administration during pregnancy in relapsed acute promyelocytic leukemia 466
Biological features of acute myeloid leukemia in the elderly 466
Clinical implications of cytokine and soluble receptor measurements in patients with newly-diagnosed aggressive non-Hodgkin's lymphoma 465
Minimally differentiated acute myeloid leukemia (AML-MO): Comparison of 25 cases with other French-American-British subtypes 465
Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia 464
Bone marrow necrosis as a terminal complication of a very long-lasting polycythemia vera 462
Clinical relevance of minimal residual disease detection in adult acute myeloid leukemia 461
Response to B-cell-depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura 459
Analysis of regulatory T cell changes in patients with idiopathic thrombocytopenic purpura receiving B-cell depleting therapy with rituximab 459
Soluble factors levels in the initial staging of high-grade non-Hodgkin's lymphomas 458
In vitro down-regulation of bcl-2 expression by all-trans retinoic acid in AML blasts 458
P-glycoprotein and BCL-2 levels predict outcome in adult acute lymphoblastic leukaemia 452
In vitro infection of leukemic bone marrow with HTLV-I generates immortalized cell lines expressing T or myeloid cell phenotype 451
Monocytes/macrophages but not T lymphocytes are the major targets of the CCL3/CCL4 chemokines produced by CD38(+)CD49d(+) chronic lymphocytic leukaemia cells 450
Lecam1/Icam1 ratio identifies a distinct pattern on normal and myelodysplastic bone marrow CD34+ progenitors cells 449
Activation-induced cytidine deaminase and CD38 expression in B-cell chronic lymphocytic leukemia 448
AML-M0: a biological and clinical profile 448
Graft failure due to hemolytic uremic syndrome recurrence 447
Chronic lymphocytic leukemia-associated immune thrombocytopenia treated with rituximab: a retrospective study of 21 patients 446
Chromosomal aberration of the 11q23 locus in acute leukemia and frequency of MLL gene translocation: results in 378 adult patients 446
CD7 Expression in acute myeloid leukemia 446
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia 446
Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia. 446
FISH analysis for CML monitoring? 445
A scoring system based on the expression of six surface molecules allows the identification of three prognostic risk groups in B-cell chronic lymphocytic leukemia 444
Biological pattern of AML-M0 versus AML-M1: Response 444
NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: Evidence for a NOTCH1 mutation-driven epigenetic dysregulation 444
Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab 442
Complete regression of cutaneous lesions of refractory Ph+ ALL after 4 weeks of treatment with BMS-354825 442
Management of hematological malignancies in patients affected by renal failure 440
The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: a retrospective multicentric GIMEMA experience 440
Gelatinous degeneration of the bone marrow: two case reports showing different hematological features and clinical outcomes 440
Clinical heterogeneity of idiopathic CD4+T lymphocytopenia 440
Pure erythroid leukemia in advanced breast cancer. 440
Molecular characterization of Ph' + hybrid acute leukemia 439
Cutaneous involvement in multiple myeloma and bortezomib 437
Hodgkin disease subsequent to follicular lymphoma on maintenance rituximab 437
Contribution of immunophenotypic and genotypic analysis to the diagnosis of acute leukemia 437
Mitoxantrone in combination with etoposide and cytarabine for treatment of poor prognosis acute non lymphoid leukemia patients 436
Clinical implication of cytokine and soluble receptor measurements in patients with newly diagnosed aggressive non Hodgkin Lymphomas 435
Multidimensional flow cytometry for detection of minimal residual disease in acute myeloid leukemia 435
Minimally differentiated acute myeloid-leukemia (aml-mo): cytochemical, immunophenotypic and cytogenetic analysis of 19 cases 435
Clinical significance of soluble p53 protein in B-cell chronic lymphocytic leukemia 432
Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia 432
Discriminant function analysis as decision support system for the diagnosis of acute leukemia with a minimal four color screening panel and multiparameter flow cytometry immunophenotyping 430
How would I manage a sample submitted for flow cytometry analysis for suspicious chronic lymphocytic leukaemia 429
CD49d expression in chronic lymphocytic leukemia: a prognostic parameter and a therapeutic target 429
IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia. 429
A shorter time to the first treatment may be predicted by the absolute number of regulatory T-cells in patients with Rai stage 0 chronic lymphocytic leukemia 427
All-trans retinoic acid and low dose cytosine arabinoside for the treatment of "poor prognosis" acute myeloid leukemia 427
Role of human leukocyte interferon-alpha in the treatment of patients with polycythemia vera 427
Red blood cell depletion and cryopreservation of umbilical cord blood (UCB) 426
Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML-M0) 426
Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation 423
ZAP-70 expression in B-cell chronic lymphocytic leukemia: evaluation by external (isotypic) or internal (T/NK cells) controls and correlation with IgV(H) mutations 423
Cytogenetic and molecular diagnostic characterization combined to post-consolidation minimal residual disease assessment by flow-cytometry improves risk stratification in adult acute myeloid leukemia 421
Minimally differentiated acute myeloid leukemia (AML-MO): A distinct clinico-biologic entity with poor prognosis 420
CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival 420
High interleukin-6 plasma levels in acute promyelocytic leukemia 420
Potential therapeutic role of antagomiR17 for the treatment of chronic lymphocytic leukemia. 420
Analysis of IgV gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery 419
Fluorescence in situ hybridization and conventional cytogenetics for the diagnosis of 11q23(+)/MLL+ translocation in leukaemia 419
Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia. 418
Totale 46.165
Salva come PNG Salva come JPEG
Categoria #
all - tutte 192.665
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 192.665
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.098 0 282 61 107 39 206 119 112 115 222 138 697
2022/20232.879 362 240 206 281 194 631 269 165 286 10 182 53
2023/2024875 101 35 39 15 101 297 44 29 19 11 14 170
2024/20254.519 152 1.210 582 250 61 187 400 207 411 349 314 396
2025/20267.720 680 350 1.094 630 605 305 862 944 892 692 339 327
2026/2027735 403 332 0 0 0 0 0 0 0 0 0 0
Totale 86.774